UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 10, 2008
Commission File Number 000-52263
CAVIT SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Florida 03-0586935
(State or Other Jurisdiction (I.R.S Employer
of Incorporation or Organization) Identification Number)
27 1st Avenue
Paterson, New Jersey 07514
(Address of principal executive offices)
(973) 278-7327
(Registrant's telephone number, including area code)
1600 South Dixie Highway, Suite 500,
Boca Raton , Florida 33432
(Former address)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF CERTAIN OFFICERS; APPOINTMENT OF CERTAIN OFFICERS
As previously reported, on October 6, 2008, the Board of Directors
appointed Ms. Margaret Smyth to serve as a Director. Effective immediately after
the filing of this Current Report, Ms. Smyth will become the Interim Chief
Executive Officer of Cavit Sciences, Inc.
Ms. Smyth will succeed Colm J. King who served as our President and Chief
Executive Officer since April 2006. Mr. King unilaterally terminated his
employment agreement with Cavit Sciences, Inc. effective November 14, 2008. Mr.
King will continue to serve as a member of our Board of Directors.
Ms. Smyth is the Vice President of Operations of Falcon East Inc., the
largest importer/manufacturer of fabric, fabric covered wood and matting to the
picture framing industry on the East Coast. Aside from daily management of
office personnel and shipping/receiving, operations also include weekly payroll,
inventory/ordering, warehousing, distribution and fulfillment.
On November 10, 2008, Matthew J. Cohen resigned from his consulting
position as Chief Financial Officer of Cavit Sciences, Inc. The Board of
Directors has not decided on a successor for this position.
ITEM 8.01 OTHER EVENTS
Effective with the filing of this Current report, Cavit Sciences, Inc. will
relocate our principal administrative offices and warehouse facility to 27 1st
Avenue, Paterson, New Jersey 07514. Our new telephone number will be (973)
278-7327.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto authorized.
Date: November 14, 2008 Cavit Sciences, Inc.
By: /s/ Colm J. King
-------------------------------------
Colm J. King
President and Chief Executive Officer
2